Gary D. Hammer
-
- Hormonal Regulation and Hypertension 34
- Pituitary Gland Disorders and Treatments 25
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism 41
- Genetics top 0.5%
- Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities 35
- Glioma Diagnosis and Treatment 16
- Surgery top 0.5%
- Adrenal and Paraganglionic Tumors 56
- Behavioral Neuroscience top 2%
-
- Sexual Differentiation and Disorders 17
- Renal and related cancers 13
- Co-authors
- Tobias ElseThomas J. GiordanoHolly A. IngrahamBarbra S. MillerPaul G. GaugerGerard M. DohertyAlex C. KimAntônio Marcondes Lerário
- Journals
- Molecular and Cellular Endocrinology (12 papers)Endocrinology (12 papers)The Journal of Clinical Endocrinology & Metabolism (9 papers)
- Partner nations
- United StatesGermanyAustralia
In The Last Decade
Gary D. Hammer
139 papers receiving 9.1k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Endocrinology, Diabetes and Metabolism 4.2k
- Cancer Research 2.9k
- Genetics 1.0k
- Surgery 3.9k
- Behavioral Neuroscience 272
Countries citing papers authored by Gary D. Hammer
This map shows the geographic impact of Gary D. Hammer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Hammer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Hammer more than expected).
Fields of papers citing papers by Gary D. Hammer
This network shows the impact of papers produced by Gary D. Hammer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Hammer. The network helps show where Gary D. Hammer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gary D. Hammer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 20 | |
| 6 | 2023 | 13 | |
| 7 | 2020 | 19 | |
| 8 | 2019 | 46 | |
| 9 | 2016 | 71 | |
| 10 | Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guidelinebreakdown → | 2016 | 1010 |
| 11 | 2016 | 18 | |
| 12 | 2012 | 30 | |
| 13 | 2011 | 11 | |
| 14 | 2010 | 52 | |
| 15 | 2010 | 131 | |
| 16 | 2009 | 292 | |
| 17 | 2009 | 98 | |
| 18 | Safety, tolerability and preliminary efficacy of the anti-IGF-IR monoclonal antibody CP-751,871 in patients with sarcomas and adrenocortical tumors. | 2007 | 7 |
| 19 | 2007 | 2 | |
| 20 | 2006 | 32 |
About Gary D. Hammer
Gary D. Hammer is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Genetics, having authored 147 papers that have together received 9.2k indexed citations. Recurring topics across this work include Adrenal and Paraganglionic Tumors (56 papers), Cancer, Hypoxia, and Metabolism (41 papers), Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities (35 papers), Hormonal Regulation and Hypertension (34 papers), Pituitary Gland Disorders and Treatments (25 papers), Sexual Differentiation and Disorders (17 papers), Glioma Diagnosis and Treatment (16 papers) and Renal and related cancers (13 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (4.2k citations), Cancer Research (2.9k citations) and Genetics (1.0k citations). Gary D. Hammer has collaborated with scholars based in United States, Germany and Australia. Frequent co-authors include Tobias Else, Thomas J. Giordano, Holly A. Ingraham, Barbra S. Miller, Paul G. Gauger, Gerard M. Doherty, Alex C. Kim, Antônio Marcondes Lerário, Catherine E. Keegan and Aaron Sabolch. Their work appears in journals such as Molecular and Cellular Endocrinology, Endocrinology, The Journal of Clinical Endocrinology & Metabolism, Molecular Endocrinology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.